Jul 21, 2016 ... Gilead Sciences (GILD), which is set to report second-quarter 2016 ... In the first
quarter of 2016, Gilead's hepatitis C virus (HCV) franchise, consisting of
blockbuster drugs ... On the second-quarter call, investors should keep an eye on
the ... Here are a couple of other health care stocks that you may want to ...
Mar 2, 2016 ... The fourth quarter earnings season is winding down, with quite a ... Tesla's New
P100D: Everything You Need to Know ... Biotech Stock Roundup: Gilead HIV
Drug Approved, Baxalta in ... Gilead is quite focused on bringing new HIV
treatments to market and to boost sales of its blockbuster HIV franchise.
Jun 29, 2016 ... Analyst Activity; Upgrades/Downgrades · Forecast Changes · Earning Surprises
... Tesla's New P100D: Everything You Need to Know ... Meanwhile, Gilead
continues to expand its blockbuster HCV franchise. ... for the duvelisib program,
and will focus on submitting a NDA in the fourth quarter of 2016. 3.
Apr 7, 2016 ... Biotech Stock Roundup ... Descovy, which is considered to have blockbuster
potential, is the third ... Plans are on to submit regulatory applications in the third
quarter of the year. ... What you need to know on Wall Street right now ... Best Buy
jumps on earnings; Square gets an upgrade; Toll Brothers revenue ...
4:53 PM Zooming in on Instagram — Tech Roundup ... FDIC: Bank Income Rose
in Second Quarter Driven by Loan Growth, Trading ... 5 Things You Must Know
Before the Market Opens Wednesday ... Hedge Funds Love These 5 Stocks -- but
Should You? ... Gilead Sinking Stock Price Calls Out for New Rescue Plan ...
May 5, 2016 ... Biotech Stock Roundup. Earnings were the key focus this week with several
major biotech ... According to AbbVie, the candidate has blockbuster potential
and could ... The company plans to speed up its efforts to bring new treatments ...
investors know what stocks to buy and which to sell for the long-term.
The most recent quarterly report saw Gilead's (NASDAQ: GILD) earnings drop .....
Everything You Need To Know About Biotech Right Now (Podcast With Bret
Jensen) ... Stocks to Watch Evening Roundup: Disney's Earnings, US Steel's
Stock Sale, ... Which begs the question: Has a blockbuster drug ever been more
of an ...
Oct 1, 2014 ... News Roundup, October 2014: Walgreens, Cardinal Health, ... Yesterday, Gilead
Sciences reported another blockbuster quarter for Sovaldi sales. ... Based on the
chart below, I think you'll agree that Sovaldi is the most legendary of them all. ...
should—but probably won't—mute critics of preferred networks.
Jul 9, 2012 ... These factors could hold the key to big gains with Gilead Sciences. ... $1.84
billion of Gilead's $2.21 billion in net product sales in the first-quarter. ... Just in
case you weren't aware, the race to create the next blockbuster ... Foolish
roundup. Now that you know what to watch for, it should be easier to an...
10:04AM, AbbVie Expects Investigational Drug Elagolix to Be a Blockbuster ... 06:
30AM, Analysts: Gilead Should Divide Itself and Conquer. Aug-11-16 05:30PM,
Biotech Stock Roundup: Earnings in Focus, AbbVie Takes Steps to Block Humira
Copycat ... 08:40AM, 5 Things You Must Know Before the Market Opens Friday.